Loading…
Automating decentralized manufacturing of cell and gene therapy products.
Decentralized, or redistributed manufacture, is likely to be the manufacturing approach of choice for some cell- and gene-based therapies, in particular, personalized therapies. Such an approach will ultimately depend on the business model and will take into account the regulatory and supply chain f...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Default Article |
| Published: |
2016
|
| Subjects: | |
| Online Access: | https://hdl.handle.net/2134/23482 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|